尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Connelly Deirdre P. Officer active across 2 companies, notably Lincoln National CORP. In total, 4 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €108k. Activity tracked since 18 November 2022. The latest transaction was disclosed on 12 September 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Connelly Deirdre P has 4 filings in total. Across the 4 recent filings available, the period runs from 2022-11-18 to 2026-06-05, with EUR 108312 of buys and EUR 0 of sells, and the modal transaction nature is Attribution. She is a Director of Sarepta Therapeutics, Inc. and Lincoln National CORP.